Cargando…

Early Lung Cancer Diagnosis by Biosensors

Lung cancer causes an extreme threat to human health, and the mortality rate due to lung cancer has not decreased during the last decade. Prognosis or early diagnosis could help reduce the mortality rate. If microRNA and tumor-associated antigens (TAAs), as well as the corresponding autoantibodies,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yuqian, Yang, Dongliang, Weng, Lixing, Wang, Lianhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759869/
https://www.ncbi.nlm.nih.gov/pubmed/23892596
http://dx.doi.org/10.3390/ijms140815479
_version_ 1782282698768777216
author Zhang, Yuqian
Yang, Dongliang
Weng, Lixing
Wang, Lianhui
author_facet Zhang, Yuqian
Yang, Dongliang
Weng, Lixing
Wang, Lianhui
author_sort Zhang, Yuqian
collection PubMed
description Lung cancer causes an extreme threat to human health, and the mortality rate due to lung cancer has not decreased during the last decade. Prognosis or early diagnosis could help reduce the mortality rate. If microRNA and tumor-associated antigens (TAAs), as well as the corresponding autoantibodies, can be detected prior to clinical diagnosis, such high sensitivity of biosensors makes the early diagnosis and prognosis of cancer realizable. This review provides an overview of tumor-associated biomarker identifying methods and the biosensor technology available today. Laboratorial researches utilizing biosensors for early lung cancer diagnosis will be highlighted.
format Online
Article
Text
id pubmed-3759869
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-37598692013-09-03 Early Lung Cancer Diagnosis by Biosensors Zhang, Yuqian Yang, Dongliang Weng, Lixing Wang, Lianhui Int J Mol Sci Review Lung cancer causes an extreme threat to human health, and the mortality rate due to lung cancer has not decreased during the last decade. Prognosis or early diagnosis could help reduce the mortality rate. If microRNA and tumor-associated antigens (TAAs), as well as the corresponding autoantibodies, can be detected prior to clinical diagnosis, such high sensitivity of biosensors makes the early diagnosis and prognosis of cancer realizable. This review provides an overview of tumor-associated biomarker identifying methods and the biosensor technology available today. Laboratorial researches utilizing biosensors for early lung cancer diagnosis will be highlighted. MDPI 2013-07-25 /pmc/articles/PMC3759869/ /pubmed/23892596 http://dx.doi.org/10.3390/ijms140815479 Text en © 2013 by the authors; licensee MDPI, Basel, Switzerland http://creativecommons.org/licenses/by/3.0 This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Zhang, Yuqian
Yang, Dongliang
Weng, Lixing
Wang, Lianhui
Early Lung Cancer Diagnosis by Biosensors
title Early Lung Cancer Diagnosis by Biosensors
title_full Early Lung Cancer Diagnosis by Biosensors
title_fullStr Early Lung Cancer Diagnosis by Biosensors
title_full_unstemmed Early Lung Cancer Diagnosis by Biosensors
title_short Early Lung Cancer Diagnosis by Biosensors
title_sort early lung cancer diagnosis by biosensors
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759869/
https://www.ncbi.nlm.nih.gov/pubmed/23892596
http://dx.doi.org/10.3390/ijms140815479
work_keys_str_mv AT zhangyuqian earlylungcancerdiagnosisbybiosensors
AT yangdongliang earlylungcancerdiagnosisbybiosensors
AT wenglixing earlylungcancerdiagnosisbybiosensors
AT wanglianhui earlylungcancerdiagnosisbybiosensors